DaxdilimabDaxdilimab
MedChemExpress (MCE)
HY-P99226
2245966-28-1
MEDI7734
VIB7734
96.58%
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping with dry ice.
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research.
Human
Human IgG1 lambda1
Human IgG1 lambda1, Isotype Control
| | | |
| | | | | |
[1]. Patel S, et al. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. 2021 Feb
7(2):e06158. [Content Brief]
[2]. Retamozo S, et al. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opin Pharmacother. 2021 Dec
22(17):2359-2371. [Content Brief]